Similar to the results observed in smoking patient samples, immunohistochemistry in tumor sections of NIC-treated (0.25 mg/kg body weight, 80 days) mice showed 30% enhanced EZH2 expression (Fig. 4a, b) . Here, EZH2 is linked to neoplasm.